Physician profile
William C Dillon
NPI 1053340141
$4,161.72
in general payments reported to CMS, 2019-2025
26 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $1,582 · 2021: $180 · 2022: $534 · 2023: $482 · 2024: $461 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,267 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.43 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,767.10 | 2019-2020 | |
| Boston Scientific Corporation | $569.92 | 2019-2025 | Avvigo Guidance System, General - Balloon Catheters, Rotapro |
| Pfizer INC. | $209.72 | 2021-2025 | |
| Terumo Medical Corporation | $189.18 | 2019-2024 | Metacross Otw |
| Novo Nordisk INC | $161.98 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $159.78 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $144.85 | 2021-2022 | |
| Abbott Laboratories | $135.25 | 2022-2023 | Pressurewire |
| Abiomed | $117.38 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $117.36 | 2019-2025 | |
| Inari Medical, INC. | $87.87 | 2019-2022 | |
| Edwards Lifesciences Corporation | $69.98 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astellas Pharma US INC | $58.16 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $58.09 | 2019-2021 | |
| Shockwave Medical, INC | $44.89 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $42.15 | 2025 | Flowtriever |
| Teleflex LLC | $40.40 | 2024-2025 | Trapliner, Guardian |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.53 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $27.43 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.14 | 2025 | Jardiance |
| Surmodics, INC. | $24.17 | 2024 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy |
| Kiniksa Pharmaceuticals, Ltd. | $20.69 | 2023 | Arcalyst |
| Atricure, INC. | $15.96 | 2021 | |
| Philips North America LLC | $15.59 | 2025 | Mcot |
| Regeneron Healthcare Solutions, INC. | $15.42 | 2023 | Evkeeza |
| Genzyme Corporation | $14.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.